High-Purity Ursodeoxycholic Acid (UDCA) API: Pharmaceutical Grade for Bile Acid Treatments
Discover the therapeutic power of Ursodeoxycholic Acid, a key API for liver health and gallstone management.
Get a Quote & SampleProduct Core Value
Ursodeoxycholic Acid
Ursodeoxycholic Acid (UDCA) is a crucial bile acid API recognized for its therapeutic benefits in managing liver diseases and dissolving cholesterol gallstones. Its pharmaceutical grade quality ensures efficacy and safety in various medical applications, making it a vital component in modern therapeutics.
- Experience superior liver health support with high-purity Ursodeoxycholic Acid API, addressing conditions like Primary Biliary Cholangitis (PBC) with proven effectiveness.
- Discover efficient gallstone dissolution using our pharmaceutical-grade UDCA, a safe and reliable option for managing biliary disorders.
- Benefit from GMP-certified Ursodeoxycholic Acid API, manufactured under stringent quality standards to guarantee batch-to-batch consistency and safety.
- Secure comprehensive regulatory support, including CEPs and DMFs, for your pharmaceutical formulations with our trusted UDCA API.
Advantages in Product Application
Enhanced Liver Function
UDCA API plays a pivotal role in improving liver enzyme levels and protecting liver cells from toxic bile damage, crucial for patients with liver conditions.
Effective Gallstone Management
As a choleretic and cholagogue, UDCA aids in dissolving cholesterol-rich gallstones, offering a non-surgical therapeutic approach.
Therapeutic Versatility
Beyond liver diseases and gallstones, UDCA is also researched for its potential in managing conditions like Type 2 Diabetes and protecting against viral infections, showcasing its broad therapeutic scope.
Key Applications
Primary Biliary Cholangitis (PBC) Treatment
Ursodeoxycholic Acid is the first-line treatment for PBC, effectively slowing disease progression and improving liver function by replacing toxic bile acids with less harmful UDCA.
Cholesterol Gallstone Dissolution
UDCA offers a non-surgical option for dissolving cholesterol gallstones by altering bile composition and reducing cholesterol saturation.
Biliary Reflux Gastritis Management
The API helps manage biliary reflux gastritis and other bile duct inflammations by improving bile flow and protecting epithelial cells.
Cystic Fibrosis Hepatobiliary Support
UDCA is used clinically to address hepatobiliary disorders associated with cystic fibrosis, particularly in pediatric patients, improving liver enzyme levels.